Motivation: Whole genome DNA-sequencing (WGS) of paired tumor and normal samples has enabled the identification of somatic DNA changes in an unprecedented detail. Large-scale identification of somatic structural variations (SVs) for a specific cancer type will deepen our understanding of driver mechanisms in cancer progression. However, the limited number of WGS samples, insufficient read coverage, and the impurity of tumor samples that contain normal and neoplastic cells, limit reliable and accurate detection of somatic SVs.
Introduction
Genomic mutation analysis has been accelerated with the accumulation of DNA sequencing data acquired from exome regions to whole genome. Somatic mutations are likely to be critical factors determining how tumors progress and respond to treatments. To help optimize cancer therapy and predict long-term prognosis, it is important to identify somatic mutations. Structural variation (SV), a major type of genomic mutation (Feuk et al., 2006) , has been characterized in several studies (Freeman et al., 2006; Yang et al., 2013) . Increasing volumes of whole genome sequencing (WGS) data have been generated from paired tumor-normal samples, for example The Cancer Genome Atlas (TCGA) project. Thus, it is now possible to identify somatic SVs by comparing the sequence data of a tumor sample with that of its matched normal sample (Koboldt et al., 2012; Malhotra et al., 2013; Mills et al., 2011) . Nevertheless, the lack of powerful computational methods poses challenges to the accuracy of somatic SV identification.
BreakDancer (Chen et al., 2009) was first developed to predict basic types of SVs (i.e. deletion, insertion, inversion and translocation) using discordantly mapped reads from one or multiple WGS data samples. GASVPro (Sindi et al., 2012) integrates read coverage and discordant reads for deletion and inversion prediction only. These two early SV detection methods were not developed for somatic SV prediction. CREST uses soft-clipped reads to identify breakpoints of SVs in tumor or normal samples and then predicts mutation regions unique in tumor samples as somatic SVs. However, not all SVs have soft-clipped reads hence CREST usually predicts a short list of somatic SVs. Delly (Rausch et al., 2012) and Lumpy (Layer et al., 2014) integrate soft-clipped reads and discordant reads for somatic SV prediction. They work well with small-scale SVs but cannot predict large-scale SVs like inter-or intra-chromosome translocations. Note that only BreakDancer can predict all basic types of SVs but it was not developed for somatic SV prediction. Existing somatic SV prediction tools predict SVs in tumor and normal samples independently and then use a filtering step to extract unique SVs in tumor samples as somatic SV prediction. There are at least three factors that lower the confidence of SVs predicted from such two-step approach. First, it is well known that germline mutations significantly outnumber somatic mutations (Malhotra et al., 2013) . High sensitivity for somatic SV prediction requires accurate differentiation between somatic and germline SVs (Christoforides et al., 2013; Escaramis et al., 2013) , rather than a requirement only for somatic SVs. Secondly, the impurity of tumor samples increases the difficulty in differentiating somatic mutations from germline mutations. The contamination of normal cells should be removed before somatic region calling; otherwise, read counts calculated in tumor samples are not accurate. The proportion of normal cells can be estimated by THetA (Oesper et al., 2013) using WGS data or tools using other types of data (Aran et al., 2015) . Finally, the mutation status on two copies of each chromosome is neglected by most SV detection methods (except for GASVPro and Delly). Cells with heterozygous mutations may function normally with the wild type copy until the latter becomes somatically mutated. Measuring somatic homozygous mutations is important in predicting the rate at which a person may develop cancer (Araten et al., 2005) . Note that the chromosome diploid feature has been utilized in computational modeling of SVs (Sindi et al., 2012) , single nucleotide variant (Saunders et al., 2012) and copy number variation (Klambauer et al., 2012) .
We developed a pattern-based probabilistic approach (PSSV) for somatic SV prediction by jointly modeling discordant and concordant read counts (Chen et al., 2009 ) from paired samples in a Bayesian framework. PSSV is specifically designed to predict somatic deletion, inversion, insertion and translocation by considering their different formation mechanisms. In detail, we define the 'true' mutation pattern (mutation situations in paired normal and tumor samples) of a SV as one of six states including three 'somatic', two 'germline' and one 'none' (as a special case of 'germline'). Under each state, the discordant and concordant read counts are assumed to follow specific Poisson distributions. Note that the discordant and concordant read counts in tumor samples are properly normalized to remove normal cell contamination. Then, each SV identified from paired samples of individual patient is modeled as a mixture of hidden states. A Poisson mixture distribution is then introduced to each type of read count. Through an expectation-maximization (EM) algorithm, we iteratively estimate the prior probability for each state as well as the parameters of the Poisson mixture distribution. For an individual SV, we can then estimate a posterior probability vector representing the possibility that its mutation pattern can be explained by a specific state. Finally, we select a pattern with the largest probability for SV state prediction and then cluster all SVs into either somatic or germline catalogs.
The proposed PSSV approach is first evaluated by simulation studies. Our simulation results show that PSSV is robust against the noise in WGS data caused by mapping errors and imperfect classification of discordant reads. The precision-recall performance of PSSV is better than that of existing approaches, especially for predicting somatic SVs with homozygous status in the tumor sample and heterozygous status in the normal sample. We further applied PSSV to 14 TCGA breast cancer samples and compared the predicted somatic SVs to another independent study (Malhotra et al., 2013) using a similar dataset. After a detailed examination of the results of PSSV, we have not only identified several frequent somatic SVs (which are reported by another breast cancer study (Koboldt et al., 2012) using whole exome sequencing data), but have also observed some somatic SVs on a high fraction of Polycomb-group (PcG) genes. PcG genes can act as tumor suppressors, and their malfunction may trigger cancer progression (Di Croce and Helin, 2013) . Further, for somatic deletion, after removing any deletions reported by 1000GP (Mills et al., 2011) that occur in normal population, we observed functional enrichments on PI3K-AKT signaling, RAP1 signaling and RAS signaling pathways. By examining the expression change of each gene between tumor samples with and without somatic SVs, we collected more evidence to support the causal relationship between somatic mutations and gene expression changes.
Methods

Overview of PSSV
The workflow of the proposed PSSV approach is shown in Figure 1 . First, we identify a candidate SV pool from a pair of tumor and normal samples by hierarchical clustering of discordant reads in each. Types of SVs include deletion, insertion, inversion and translocation, as illustrated in Supplementary Figure S1 . The proportion of normal cells in the tumor sample is estimated for the removal of tumor sample impurity; the discordant read counts are calculated in the 'purified' tumor sample. For each SV, the concordant reads mapped around the mutation region are also counted. Then, each type of read count is assumed to follow a Poisson mixture distribution with three components respectively representing non-mutation, heterozygous and homozygous mutation statuses. Non-mutation, heterozygous and homozygous mutation statuses in each sample can be modeled according to local alignments of discordant and concordant reads. Considering the mutation statuses in a pair of tumor and normal samples, patterns of somatic or germline SVs can be characterized by six hidden states. Using a Bayesian framework, PSSV analyzes discordant and concordant read counts jointly from paired samples, and iteratively estimates the prior probability and the Poisson distribution parameters for each hidden state, and the posterior probability for an individual SV using the EM algorithm. Finally, highly confident somatic SVs of (States 2, 3 and 5 defined in Fig. 1 ) are reported.
Candidate structural variation detection
Using the BAM format WGS data from a pair of tumor-normal samples, we use a hierarchical clustering approach (Chen et al., 2009) to generate discordant read clusters in each sample. We filter detected SVs by setting the number of discordant reads in a tumor sample !4. Then, we use GATK (McKenna et al., 2010) to calculate the average concordant read depth within each candidate SV, and its corresponding flanks, in both samples. The concordant read depth within mutation regions (referred to as read counts around midpoints of mutation regions) can improve the sensitivity of somatic SV prediction. The read depth signals at both flanks can be used to normalize local read counts and eliminate GC bias and large scale copy number change, making the read counts comparable across all mutation regions. To remove normal cell contamination, the discordant and concordant read counts in the tumor sample are normalized using the estimated tumor sample impurity (Aran et al., 2015; Oesper et al., 2013) . A flow chart of WGS data preprocessing for paired tumor-normal samples can be found in Supplementary Figure S2 .
PSSV model description
After having identified candidate SVs from WGS data, for the nth SV, we generate four read counts including k n;D;T and k n;C;T , discordant (D) and concordant (C) read counts in a 'purified' tumor (T) sample (after the removal of tumor sample impurity), and k n;D;N and k n;C;N , discordant and concordant read counts in the matched normal (N) sample, as shown in Figure 2 . We use index m to denote each type of read and then define a read count vector k n ¼ ½k n;1 ; . . . ; k n;m ; . . . ; k n;4 . For SV detection in a single sample, an individual SV region is formed by non-mutation, heterozygous mutation or homozygous mutation. In the PSSV model, we model each type of read count with a Poisson mixture distribution of three components as: 
where index i represents different mutation status in a single sample. More details about the Poisson mixture distributions for deletion, insertion, inversion and translocation can be found in Supplementary Figures S3-S6.
As shown in Figure 2 , for a pair of samples, we jointly model four types of read counts stored in k n to identify somatic or germline SVs. The final mutation pattern is jointly determined by mutation statuses in paired samples. Here, we use index i (0-2) and j (0-2) to denote mutation statuses in tumor and normal samples respectively. Since somatic or germline mutations refer to genomic changes from normal to tumor samples, only those mutation states with i ! j are biologically meaningful. In total we have six states (State 1-6) as shown in Figure 2 . States with i > j, like States 2, 3 and 5, represent somatic mutations. States with i ¼ j, like States 1, 4 and 6, represent germline mutations. Nonmutation (i ¼ j ¼ 0) is a special case of germline mutation. The mutation pattern of the nth SV is modeled by a mixture of six hidden states with a posterior probability vector a n ¼ fa n;ði;jÞ j0 j i 2g. Each posterior probability a n;ði;jÞ is defined by: a n;ði;jÞ ¼ Pðk n ji; jÞPði; jÞ= X j;i!j Pðk n ji; jÞPði; jÞ;
where n is the index of SV, Pðk n ji; jÞ is the joint likelihood function for State ði; jÞ, and Pði; jÞ is the prior probability for State ði; jÞ. For the likelihood function Pðk n ji; jÞ in (2), given the State ði; jÞ, the distribution of each read type is conditionally independent. Therefore, Pðk n ji; jÞ can be calculated as: Pðk n ji; jÞ ¼ Pðk n;1 jiÞPðk n;2 jiÞPðk n;3 jjÞPðk n;4 jjÞ ¼ Poisðk n;1 jk 1;i ÞPoisðk n;2 jk 2;i Þ Poisðk n;3 jk 3;j ÞPoisðk n;4 jk 4;j Þ :
Here, we define a Poisson parameter matrix k as fk m¼1ð2Þ;i ; i ¼ 0 $ 2; k m¼3ð4Þ;j ; j ¼ 0 $ 2g. Selection of k will determine the final performance for somatic SV detection. For deletion or insertion, the classification of discordant and concordant reads is based on the insert size distribution of their paired ends, where the value of the cut-off threshold will affect the number of reads and the overall distribution of each type. Therefore, the actual value of k is unknown and must be estimated. We assume a Gamma prior PðkÞ on each k as shown in (4), which is a conjugate prior of the Poisson likelihood.
where mean value (a=b) of each Gamma distribution is determined by the whole genome average read depth (ARD) in the tumor or normal sample, and its mutation status; the variance (a=b 2 ) is designed Relationship between the mutation status in each sample and six hidden states. Somatic mutation occurs during the process of transition from normal cell to neoplastic cell. Only six states (combined pattern of mutation statuses in paired samples) are biological meaningful, including three 'somatic', two 'germline' and one 'none' (as a special case of 'germline') (Color version of this figure is available at Bioinformatics online.)
to control the scale of possible parameter values by avoiding severe overlap between the components defined in (1 
Posterior probability estimation
With the probabilistic model formulated, the problem of determining whether the nth SV is a somatic or germline mutation can be mathematically stated as follows: given the model parameters (k;p) and read counts K¼fk n jn ¼ 1 $ Ng, how to estimate posterior probabilities fa n jn ¼ 1 $ Ng. Since k and p are unknown, we define a posterior probability in the following equation to estimate these parameters: 
In the following EM algorithm, we use the E-step and the M-step iteratively to update each parameter until the improvement of estimated posterior probability Pðk;pjKÞ is smaller than 10
À4
. Initial value setting of k and c can be found in Supplementary S4 and Tables S1-S4 for different SV subtypes. The EM algorithm can be summarized as follows: E-step: Based on the definition of a n;ði;jÞ in (1), using Bayes' rule, we can directly estimate a 
where s ¼ N þ P j;i>j ðc ði;jÞ À 1Þ. We then update k m;i and k m;j by maximizing (6) with the updated value of a Ã n;ði;jÞ as follows: 
Note that in our experiments testing PSSV on both simulated and real data, the EM algorithm will usually converge within 20 iterations. A minimum number of 50 SVs in each state are needed to ensure the accuracy in parameter estimation. After convergence, for the nth SV, we select the state with the highest a Ã n;ði;jÞ to represent the mutation pattern of the region. If a Ã n;ði;jÞ > 0:5 and i > j (States 2, 3 or 5), we will predict this SV as a somatic mutation. More details about the estimation of each posterior probability and each model parameter can be found in Supplementary S5.
Results
Performance evaluation by simulation studies
To evaluate PSSV's performance on somatic SV prediction, especially when discordant and concordant reads are imperfectly classified, for each SV subtype (deletion, insertion, inversion or translocation), we simulated 100 SVs for each mutation state. Discordant and concordant read counts were generated according to the Poisson mixture distributions as shown in Supplementary Figures S3-S6 . The first component represents non-mutation. The mean value is non-zero because there are always some reads false positively predicted as discordant reads. The mean value of this component would affect the detection accuracy of somatic SVs.
To test the robustness of PSSV on differentiating somatic and germline SVs, we set the ARD in each sample as 30 and varied the mean parameter of the first component from 1 to 5 in order. We added Gaussian distributed noise to all three mutation statuses in either tumor or normal sample so as to mimic inaccuracy occurring at discordant and concordant read classification. Taking deletion as an example, all discordant reads should have significantly longer insert sizes as compared with concordant reads. The insert size of concordant reads follows a Gaussian distribution. Thus, if a cut-off threshold is set at three standard deviations from the mean, some concordant reads would be falsely predicted as being discordant due to their long insert sizes. Also, some discordant reads with insert sizes less than the cut-off threshold will be missed. In real cases, the number of false discordant reads caused by classification inaccuracy is lower than that caused by inaccurate alignments, although still cannot be overlooked due to their impact on the detection of all types of mutations. We simulated multiple datasets with different noise levels and applied PSSV to each dataset to predict somatic SVs. The prediction performances on different SV subtypes are shown in Figure 3 .
For somatic deletion detection, the performance of PSSV is robust against noise even though the mean value of the first component of Poisson distribution is high (Fig. 3(a) ). The impact of Gaussian noise is evident but PSSV provides a high accuracy even when the level of Gaussian noise is high. For somatic insertion detection, only discordant read counts can be utilized since there is no concordant read depth change at insertion regions. In addition, only partial discordant reads can be recorded because some discordant reads carrying insertion information cannot be successfully aligned to the reference genome. The accuracy of somatic insertion detection degrades much faster when the level of noise, especially the Gaussian distributed noise, increases (Fig. 3(b) ). However, if the discordant read count is accurate and the Gaussian distributed noise is small, PSSV can still achieve a high accuracy on somatic insertion detection. For somatic inversion detection, as shown in Figure 3(c) , PSSV achieved robust performance under different noise conditions. The impact of Gaussian noise is much lower than that on somatic deletion or insertion detection because the insert size is not used to define inverted discordant reads, whereas the orientation of two ends of a read is considered. For somatic translocation detection, the performance is quite robust (Fig. 3(d) ) because two ends of each read used to predict translocation are either mapped to two distant locations on the same chromosome or to two different chromosomes. The ambiguity of such discordant reads is lower than that of the other SV types.
To compare PSSV with existing somatic SV prediction approaches, we used a SV simulation tool, RSVSIM (Bartenhagen and Dugas, 2013) , to simulate a pair of genomes as 'tumor' and 'normal' using a segment of human reference genome (GRCh37). We implanted 100 germline and another 100 somatic mutations for each state of deletion, insertion, inversion or translocation into the reference genome. Mutation length of each SVs is randomly selected from the real length distribution of SV detected from TCGA tumor samples, as shown in Supplementary Figure S7 . Then, we sequenced the genome using WGSIM (Li et al., 2009) . In this study, we simulated six different scenarios (Cases 1-6) by varying read coverage, read length and read insert size distribution (mean and standard deviation). For each case, we generated three replicates by randomly changing SV locations. Simulation parameters can be found in Supplementary Table S5 . Briefly, Cases 1, 2 and 3 have different read coverages: 60, 30 and 15, respectively; Cases 2 and 4 have different mean values of insert size: 350 bps and 200 bps, respectively; Cases 2, 5 and 6 have different read lengths: 100 bps, 75 bps and 150 bps, respectively. Sequenced paired-end reads were aligned to the reference genome using BWA (Li and Durbin, 2010) . The PSSV approach and five competing methods (BreakDancer (Chen et al., 2009) , CREST , Delly (Rausch et al., 2012) , GASVPro (Sindi et al., 2012) and Lumpy (Layer et al., 2014) ) were applied to the simulated data for somatic SV detection. Since each method has its own output format, we performed proper conversions of the results of each method to make it comparable to PSSV (more details can be found in Supplementary S6). Figure 4 shows the mean and standard deviation of the F-measure (2*precision*recall/(precision þ recall)) for each method on detection of each type of somatic SVs. PSSV outperforms other competing methods consistently. From Figure 4 (a)-(c) we can see that in general, a lower read coverage decreases the detection accuracy of SVs. From Figure 4 (b) and (d), we can see that most of the methods can work well with different read insert sizes and only the deletion detection performance of GASVPro drops significantly. By comparing the performances in Case 5 and 6 (Fig. 4(e) and (f)) we can note that a longer read length (Case 6) can significantly improve the detection performance. More detailed performances on each somatic state can be found in Supplementary Tables  S6-S11 . Importantly, it can be found that PSSV has a significant performance improvement on the detection of somatic SVs with State 5 (homozygous mutation in the tumor sample but heterozygous mutation in the normal sample).
Breast cancer WGS data analysis
Identification of somatic SVs from TCGA breast cancer WGS data
To demonstrate the capability of PSSV on real WGS data analysis, we analyzed 14 TCGA estrogen receptor negative (ER-) breast cancer patients with sample pairs. For each TCGA tumor sample, tumor sample impurity has been reported in (Aran et al., 2015) ; the reported proportion of normal cells can be found in Supplementary Table S12 . For other WGS datasets, tumor sample impurity can be estimated using THetA or other methods mentioned in (Aran et al., 2015) . We then applied PSSV to 'purified' tumor sample and normal sample and identified somatic SVs with State 2, 3, or 5 (posterior probability > 0.5). Taking one paired TCGA sample as an example, in Supplementary Figures S8-S11 we show that PSSV can predict candidate SVs in terms of their different states and the distribution of discordant read count for each state is correctly estimated. Specific to each somatic state, the discordant read counts were significantly different between tumor and normal samples. We then applied PSSV to the remaining 13 paired samples and predicted somatic SVs on each. In total, we identified 3876 deletions, 6672 insertions, 4003 inversions and 3862 translocations with State 2; 601 deletions, 165 insertions, 435 inversions and 188 translocations with State 3; 469 deletions, 95 insertions and 170 translocations with State 5. As shown in Figure 5 , about 1070 of deletions, 260 of insertions, 435 of inversions and 358 of translocations have homozygous mutation pattern (States 3 and 5). More detailed results for individual tumor samples can be found in Supplementary  Table S13 . To estimate the false discovery rate (FDR) of somatic SV predictions, for each pair we flipped tumor and normal samples and predicted 'somatic' regions in the normal sample using PSSV (Malhotra et al., 2013) . As shown in Supplementary Table S14, most somatic predictions have a FDR < 0.10. The length distributions of PSSVpredicted somatic SVs are shown in Supplementary Figure S12 . For insertion, due to using discordant reads with significantly shorter insert sizes (Chen et al., 2009) , we only predict insertions up to 100 bps.
Somatic SV validation
To validate somatic SVs predicted by PSSV, we compared the results of PSSV with that from another independent study on nine TCGA breast cancer samples (Malhotra et al., 2013) , in which predicted somatic deletions, inversions and translocations were computationally validated. The somatic SV prediction process in that study used multiple filtering steps and compared against SVs predicted from other tissues; the final set of validated somatic SVs includes 385 deletions, 42 inversions and 293 translocations. In addition, the authors provided about 6000 germline SVs that can be used to estimate the false positive rate of somatic predictions. As a result, in total we have validated 121 somatic deletions, 11 somatic inversions and 33 translocations; the false positive rate of PSSV-predicted somatic SVs in each sample is less than 0.01. The number of validated somatic SVs and the false positive rate of each sample are summarized in Supplementary Table S15 .
We proceeded to investigate the PSSV-identified genes in available databases to check whether PSSV had captured somatic SVs occurring at any known breast cancer specific genes. In a previous study (Koboldt et al., 2012; Mills et al., 2011) , researchers reported 20 breast cancer related genes with somatic copy number variations using whole exome sequencing data of 507 TCGA breast cancer patients, including all individuals used in our analysis. PSSV successfully captured 10 genes. We further compared our results with available literature and identified another six breast cancer related genes. The posterior probabilities of the somatic SVs occurring at these sixteen breast cancer specific genes are shown in Figure 6 (a). We found that MLL3 and PIK3CA, with frequent mutations in multiple types of human tumors including breast cancer (Karakas et al., 2006; , contained somatic deletions, insertions, or inversions in multiple samples. It has been also known that somatic genetic alteration of the Polycomb-group (PcG) genes predisposes normal cells to various types of disease (Di Croce and Helin, 2013) . PcG genes are known tumor suppressor genes, whose target genes have been demonstrated to be predictive for breast cancer prognosis (Jene-Sanz et al., 2013) . Among the 30 PcG genes reported in (Di Croce and Helin, 2013) , PSSV predicted 13 genes with somatic SVs, of which the posterior probabilities are shown in Figure 6 (b).
Refining somatic SVs by excluding population variants
Due to the limited number of breast cancer tumor samples used in this study, some predictions of PSSV may not be breast cancer specific. The Structure Variation Analysis Group (SVAG) identified 22 025 deletions from 179 unrelated individuals in 1000GP (Mills et al., 2011) . If a breast cancer somatic SV matches a variant identified from this normal human population, such calls are more likely to be nonsomatic, or non-tumor related. We compared 4946 PSSV-detected somatic deletions with any known variants in the normal human population to exclude spurious somatic calls. There are 4705 ($95%) somatic deletions without any overlap with normal deletions.
We are interested in somatic SVs that lay in functional genomic regions like promoter and coding regions. Therefore, we extracted gene coding regions from UCSC human reference genome hg19. For each gene, its upstream and downstream 10k bps from the transcription starting site is defined as promoter region. We finally found 1090 genes with somatic deletions at promoter or coding regions. Pathway enrichment results of these somatic genes using DAVID (Huang et al., 2009) can be found in Supplementary Table S17 . Enrichment of PI3K-AKT signaling pathway is quite consistent to the previous mutation observation on PIK3CA. It may be interesting to find that RAP1 signaling and RAS signaling pathways are enriched here. RAP1 activation has been found to associate with breast cancer metastasis progression (McSherry et al., 2011) , which is more possible to occur among ER-breast cancer patients. Targeting RAP1 signaling could provide a means to control metastasis of breast cancer. It was previously reported that RAS mutations are rare in breast cancer (Bamford et al., 2004) , but alterations in upstream regulators and downstream effectors activate RAS pathway frequently (Downward, 2003) . In this study, we have identified breast cancer somatic mutations on 21 genes involved in RAS signaling pathway.
3.2.4 Impact of somatic SVs on gene expression pattern mRNA abundance provides a quantitative evaluation of gene expression and RNA-seq data can be used to confirm genomic mutations (Network, 2012) . We downloaded the RNA-seq data for the previously selected 14 TCGA tumor samples. There are 965 genes exhibiting somatic SVs (including deletions, insertions and inversions) in at least two samples ( Supplementary Fig. S13 ). We extracted their gene expression data (level 3) from all downloaded RNA-seq profiles. For each candidate gene, we evaluated differential expression between the samples with and without somatic SVs. Finally, in total 184 ($20%) differential genes were selected with fold changes > 2; the gene list can be found in Supplementary Table  S18 . Functional enrichment analysis using DAVID shows that MAPK signaling pathway and p53 signaling pathway are enriched, respectively. In the KEGG pathway database, these two signaling pathways are closely linked with PI3K-AKT signaling pathway.
Discussion
A pattern based probabilistic model (PSSV) has been developed for somatic SV prediction using paired tumor-normal WGS data. Based on both simulation and real TCGA breast cancer WGS data studies, we have demonstrated that PSSV can predict highly confident somatic SVs using a probabilistic model with multiple hidden states. Model parameters are learned from discordant and concordant read counts during the EM iteration procedure of PSSV.
Intra-tumor heterogeneity presents a major challenge for DNA-seq data analysis. The number of sub-clones, population size and mutation status of each sub-clone will affect the accuracy of somatic mutation prediction (Cibulskis et al., 2013) , especially on heterozygous and homozygous state prediction of using PSSV. If somatic mutation does occur in one or several sub-clones and the population size is large, PSSV will predict this mutation as somatic because its discordant read count is higher than that in the matched normal sample. The sum of the posterior probabilities of the three somatic states defined in PSSV should be larger than the sum of the probabilities of germline states. However, in some cases it would be hard to claim which state can best represent current mutation pattern because the posterior probability calculated by PSSV for any one out of the three somatic states may not be significantly higher than that of the other two. The posterior probability of each SV should be examined before a final prediction can be made. For tumor samples with very complex intra-tumor heterogeneity, we recommend using PSSV to only predict somatic status rather than using a specific state to denote the mutation pattern. More discussions on the effects of intra-tumor heterogeneity and large-scale copy number change can be found in Supplementary Material S8.
As noted before, using discordant reads PSSV can only identify short insertions. Reads sequenced around insertion regions cannot be fully mapped to the reference genome because a certain segment is unknown. While some methods use a re-alignment technique to collect more reads carrying insertion signals, this problem is still not fully solved. Reads with longer insert size and high read coverage are needed to overcome the current bottleneck of insertion detection. Besides the four basic SV types mentioned previously, SVs also include some other complex patterns, e.g. tandem duplication. Tandem duplication (with discordant paired-end reads mapping out of order but with proper orientations) is different from copy number gain, although it also results in a significant increase of read coverage. Since an SV of tandem duplication may contain one, two or more duplications, it cannot be modeled by the heterozygous/homozygous hypothesis, nor can it be predicted by the current framework of PSSV. In the future, we may extend PSSV for somatic tandem duplication prediction using multiple Poisson components to fit the discordant read (or read coverage) distribution of multiple duplications of each region.
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